News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

ADHB Challenges Bio-Tech Co.Over Claim For Patent

ADHB CHALLENGES BIO-TECH COMPANY OVER CLAIM FOR PATENT FEES

Auckland District Health Board is taking pre-emptive legal action against the Melbourne-based biotech company Genetic Technologies Ltd (GTG).

GTG holds patents which it claims cover the use and analysis of non-coding DNA. It has demanded substantial licence fees for standard DNA tests (such as those for cystic fibrosis) carried out by public health providers in New Zealand, and has threatened the ADHB with legal action for infringement of its patents.

Initially, GTG demanded from the public health sector an upfront payment of $10 million dollars along with an annual licence of $2 million a year. Later, after ADHB raised issues about the patents, the demand was reduced to a 'one off' licence fee of AU$560,000.

ADHB General Counsel, Bruce Northey, said ADHB decided to challenge GTG after subjecting its demands to rigorous scientific and legal scrutiny. ADHB is satisfied that its DNA testing does not infringe the patents and doubts that the patent claims are valid. GTG failed to answer specific questions about the application of its patents to ADHB's tests despite repeated requests for it to do so.

"Nowhere else in the world is a public health provider paying licence fees to GTG for tests that are standard globally," he said. "It is curious that GTG has chosen to make such demands in New Zealand for the first time."

Mr Northey said the ADHB's position was that, while New Zealand encourages and supports research and development and the commercial protection of this through patents, patent licence demands needed to be subjected to proper scrutiny before public money was spent.

The ADHB issued proceedings in the High Court in Auckland last week.

ENDS


© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION